Performance of a dosage individualization table for extended interval gentamicin in neonates beyond the first week of life

References

• Nestaas E, Bangstad HJ, Sandvik L, et al. Aminoglycoside extended interval dosing in neonates is safe and effective: a meta-analysis. Arch Dis Child Fetal Neonatal Ed 2005;90:F294–300
   PubMed Web of Science ®Google Scholar
• Rao SC, Srinivasjois R, Hagan R, et al. One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates. Cochrane Database Syst Rev 2006;1:CD005091
   PubMedGoogle Scholar
• Hoff DS, Wilcox RA, Tollefson LM, et al. Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates. Pharmacotherapy 2009;29:1297–305
   PubMed Web of Science ®Google Scholar
• Gooding N, Elias-Jones A, Shenoy M. Gentamicin dosing in neonatal patients. Pharm World Sci 2001;23:179–80
   PubMedGoogle Scholar
• Fullas F, Padomek MT, Thieman CJ, Van Gorp AE. Comparative evaluation of six extended-interval gentamicin dosing regimens in premature and full-term neonates. AJHP 2011;68:52–6
   Web of Science ®Google Scholar
• deHoog M, Mouton JW, Schoemaker RC, et al. Extended-interval dosing of tobramycin in neonates: implications for therapeutic drug monitoring. Clin Pharmacol Ther 2002;71:349–58
   PubMed Web of Science ®Google Scholar
• Touw DJ, Westerman EM, Sprij AJ. Therapeutic drug monitoring of aminoglycosides in neonates. Clin Pharmacokinet 2009;48:71–88
   PubMed Web of Science ®Google Scholar
• Boyle EM, Brookes I, Nye K, et al. Random gentamicin concentrations do not predict trough levels in neonates receiving once daily fixed dose regimens. BMC Pediatr 2006;6:8
   PubMedGoogle Scholar
• Murphy JE, Roether AM. Two nomograms for determining extended-dosing intervals for gentamicin in neonates. Am J Health Syst Pharm 2008;65:624–30
   PubMed Web of Science ®Google Scholar
• Young TE, Mangum B, eds. Antibiotics. In: Neofax®. 23rd ed. Montvale, NJ: Thompson Reuters; 2010:50–1
   Google Scholar
• Mercado MC, Brodsky NL, McGuire MK, et al. Extended interval dosing of gentamicin in preterm infants. Am J Perinatol 2004;21:73–7
   PubMed Web of Science ®Google Scholar
• de Alba Romero C, Gomez Castillo E, Manzanares Secades C, et al. Once-daily gentamicin dosing in neonates. Pediatr Infect Dis J 1998;17:1169–71
   PubMed Web of Science ®Google Scholar
• Hayani KC, Hatzopoulos FK, Frank AL, et al. Pharmacokinetics of once daily dosing of gentamicin in neonates. J Pediatr 1997;131:76–80
   PubMed Web of Science ®Google Scholar
• Agarwal G, Rastogi A, Pyati S, et al. Comparison of once-daily versus twice-daily gentamicin dosing regimens in infants > or =2500 g. J Perinatol 2002;22:268–74
   PubMedGoogle Scholar
• English M, Mohammed S, Ross A, et al. A randomised, controlled trial of once daily and multidose daily gentamicin in young Kenyan infants. Arch Dis Child 2004;89:665–9
   PubMed Web of Science ®Google Scholar
• Hale LS, Durham CR. A simple, weight-based, extended interval gentamicin dosage protocol for neonates. Am J Health Syst Pharm 2005;62:1613–16
   PubMed Web of Science ®Google Scholar
• Hansen A, Forbes P, Arnold A, et al. Once-daily gentamicin dosing for the preterm and term newborn: proposal for a simple regimen that achieves target levels. J Perinatol 2003;23:635–9
   PubMedGoogle Scholar
• Rastogi A, Agarwal G, Pyati S, et al. Comparison of two gentamicin dosing schedules in very low birth weight infants. Pediatr Infect Dis J 2002;21:234–40
   PubMed Web of Science ®Google Scholar
• Avent ML, Kinney JS, Istre GR, et al. Gentamicin and tobramycin in neonates: comparison of a new extended dosing interval regimen with a traditional multiple daily dosing regimen. Am J Perinatol 2002;19:413–19
   PubMed Web of Science ®Google Scholar
• Ohler, KH, Menke JA, Fuller L. Use of higher dose extended interval aminoglycosides in a neonatal intensive care unit. Am J Perinatol 2000;17:285–90
   PubMed Web of Science ®Google Scholar
• Martinkova J, Pokorna P, Zahora J, et al. Tolerability and outcomes of kinetically guided therapy with gentamicin in critically ill neonates during the first week of life. Clin Ther 2010;32:2400–14
   PubMed Web of Science ®Google Scholar
• Dersch-Mills D, Akierman A, Alshaikh B, Yusuf K. Validation of a dosage individualization table for extended-interval gentamicin in neonates. Ann Pharmacother 2012;46:935–42
   PubMed Web of Science ®Google Scholar
• Alshaikh B, Dersch-Mills D, Taylor R, et al. Extended interval dosing of gentamicin in premature neonates ≤28-week gestation. Acta Paediatrica 2012;101:1134–9
   PubMed Web of Science ®Google Scholar
• Turnidge J. Pharmacodynamics and dosing of aminoglycosides. Infect Dis Clin N Am 2003;17:503–28
   PubMed Web of Science ®Google Scholar
• Kearns GL, Abdel-Rahman SM, Alander SW, et al. Developmental pharmacology – drug disposition, action, and therapy in infants and children. N Engl J Med 2003;349:1147–57
   Web of Science ®Google Scholar
• Craig WA. Once-daily versus multiple-daily dosing of aminoglycosides. J Chemother 1995;7:47–52
   PubMed Web of Science ®Google Scholar
• Lacy MK, Nicolau DP, Nightingale CH, et al. The pharmacodynamics of aminoglycosides. Clin Infect Dis 1998;27:23–7
   PubMed Web of Science ®Google Scholar
• Swan SK. Aminoglycoside nephrotoxicity. Semin Nephrol 1997;17:27–33
   PubMed Web of Science ®Google Scholar
• Schentag JJ, Meagher AK, Jelliffe RW. Aminoglycosides. In: Burton ME, Shaw LM, Schentag JJ, et al., ed. Applied pharmacokinetics & pharmacodynamics. 4th ed. Baltimore, MD: Lippincott, Williams & Wilkins; 2006:285–327
   Google Scholar
• Rybak MJ, Abate BJ, Kang SL, et al. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed ototoxicity and nephrotoxicity. Antimicrob Agents Chemother 1999;43:1549–55
   PubMed Web of Science ®Google Scholar
• Fanos V, Cataldi L. Antibacterial-induced nephrotoxicity in the newborn. Drug Drug Safety 1999;20:245–67
   PubMed Web of Science ®Google Scholar
• De Cock RF, Allegaert A, Brussee JM, et al. Simultaneous pharmacokinetic modeling of gentamicin, tobramycin and vancomycin clearance from neonates to adults: towards a semi-physiological function for maturation in glomerular filtration. Pharm Res 2014;31:2643–54
   PubMed Web of Science ®Google Scholar